INS and type 2 diabetes mellitus: Despite educational campaigns and pharmaceutical advances with regard to the treatment of conditions characterized by aberrant blood glucose and insulin homeostasis through diet and medications, the incidence of type 2 diabetes and CHD continues to rise, and remain among the top ten causes of death in the US and internationally [15,19].